Skip to main content
OpenTrials

Clinical trial condition

Rotavirus Infections

Explore clinical trials studying Rotavirus Infections. Study availability and eligibility vary by location and protocol.

90 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Rotavirus Infections trial results

Completed

To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination

NCT00353366

Conditions
Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +7 more
Locations
  • GSK Investigational Site Alabang, Muntinlupa City, Philippines
  • GSK Investigational Site Binangonan, Rizal, Philippines
  • GSK Investigational Site Cainta, Rizal, Philippines
  • GSK Investigational Site City of Muntinlupa, Philippines
View all 18 locations
View Trial Details
Completed

This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine

NCT03207750

Conditions
Infections, RNA Virus Infections, Reoviridae Infections, +4 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Fayetteville, Arkansas, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Daly City, California, United States
View all 47 locations
View Trial Details
Completed

A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa

NCT00263666

Conditions
Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations
  • GSK Investigational Site Attridgerville, Gauteng, South Africa
  • GSK Investigational Site Coronationville, Gauteng, South Africa
  • GSK Investigational Site Garankuwa, North West, South Africa
  • GSK Investigational Site Brits, South Africa
View Trial Details
Completed

Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks

NCT02914184

Conditions
Infections, Infections, Rotavirus, RNA Virus Infections, +4 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Anaheim, California, United States
  • GSK Investigational Site Paramount, California, United States
  • GSK Investigational Site Sacramento, California, United States
View all 66 locations
View Trial Details
Completed

Evaluation of an Infant Immunization Encouragement Program in Nigeria

NCT03870061

Conditions
Actinomycetales Infections, Arbovirus Infections, Bacterial Infections, +55 more
Locations
  • Primary Health Care facilities across Jigawa State Various Cities, Jigawa State, Nigeria
  • Primary Health Care facilities across Katsina State Various Cities, Katsina State, Nigeria
  • Primary Health Care facilities across the Zamfara State Various Cities, Zamfara State, Nigeria
View Trial Details
Completed

Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants

NCT00969228

Conditions
Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +7 more
Locations
  • GSK Investigational Site Busan, South Korea
  • GSK Investigational Site Daegu, South Korea
  • GSK Investigational Site Daegu, South Korea
  • GSK Investigational Site Daejeon, South Korea
View all 18 locations
View Trial Details

Related conditions